Navigation Links
China-Biotics, Inc. Approved to List on the Nasdaq Global Market
Date:10/14/2008

SHANGHAI, China, Oct. 14 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it has received approval to list its common stock on the Nasdaq Global Market.

China-Biotics expects to begin trading on the Nasdaq on October 23, 2008, until which time its common stocks will continue to trade on the Over the Counter Bulletin Board. The trading symbol for China-Biotics' common stock will remain "CHBT."

"We are extremely proud to be approved to list on the Nasdaq Global Market," said Mr. Jinan Song, China-Biotics' Chairman and Chief Executive Officer. "This upgrade to a prestigious senior exchange is a significant milestone for China-Biotics' growth as a public company. We believe Nasdaq is well suited for high-technology and high-growth companies like ours. With this milestone achieved, we hope to further enlarge our investor base and increase both our liquidity and visibility in the investment community."

About China-Biotics, Inc.

China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit http://www.chn-biotics.com .

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company's ability to market existing and new products, ability to access to capital for expansion, and changes from anticipated levels of sales, future national or regional economic and competitive conditions, market acceptance of its retail store concept, changes in relationships with customers, dependence on its flagship product profits and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:

CCG Investor Relations

Crocker Coulson, President

Tel: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com

Web: http://www.ccgir.com


'/>"/>
SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
2. China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility
3. China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base
4. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
5. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
6. China-Biotics, Inc. Files Application for Nasdaq Listing
7. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
8. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
9. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
10. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
11. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media has ... 2017 and Beyond. The paper outlines the key trends that are creating both ... “We’ve witnessed a lot of highs and lows as the precision agriculture market ...
(Date:5/23/2016)... LONDON , May 23, 2016 ... Boost Efficiency by 40% - Frontage Implement a Single ... Enforce Quality, Compliance and Traceability Within the Bioanalytical lab ... the United States and China ... deployed across its laboratory facilities. In addition to serving as the ...
(Date:5/22/2016)... ... May 22, 2016 , ... Doctors in Rome say micronutrients ... asbestos cancer, malignant mesothelioma. Surviving Mesothelioma has just posted an article on the new ... of Rome’s Department of Clinical Sciences and Translational Medicine evaluated more than 150 studies ...
(Date:5/20/2016)... , ... May 20, 2016 , ... Korean researchers say ... it may offer a new way to treat the disease. Surviving Mesothelioma has just ... , Scientists from several Korean institutions based their mesothelioma study on the fact ...
Breaking Biology Technology:
(Date:3/9/2016)... BEACH GARDENS, Fla. , March 9, 2016 ... identity management authentication and enrollment solutions, today announced ... DigitalPersona ® Altus multi-factor authentication ... IT and InfoSec managers to step-up security where ... Washington, DC . ...
(Date:3/3/2016)... 2016  FlexTech, a SEMI Strategic Association Partner, awarded ... & Development, Leadership in Education, and, in a category ... th year of the FLEXI Awards and the ... from past years . Judging was done on ... of criteria, by a panel of non-affiliated, independent, industry ...
(Date:3/3/2016)... NOTTINGHAM, England and DE SOTO, ... , U.S.-based Stroke Detection Plus® to offer Oncimmune,s ... the risk assessment and early detection of lung cancer ... include large employers, unions and individuals. --> ... employers, unions and individuals. --> Oncimmune, a ...
Breaking Biology News(10 mins):